• 1. An amorphous carbon nitride/NiO/CoN-based composite: a highly efficient nonprecious electrode for supercapacitors and the oxygen evolution reaction?
  Huifang Yang,Haoran Guo,Peidong Fan,Xinpan Li,Wenlu Ren,Rui Song Nanoscale, 2020,12, 7024-7034
• 2. An atom efficient route to N-aryl and N-alkyl pyrrolines by transition metal catalysis?
  Supaporn Sawadjoon,Joseph S. M. Samec Org. Biomol. Chem., 2011,9, 2548-2554
• 3. An analysis of the WTC fires using CIB correlations and simple modeling
  JGQuintiere
• 4. An asymmetric supercapacitor based on controllable WO3 nanorod bundle and alfalfa-derived porous carbon?
  Kanjun Sun,Fengting Hua,Shuzhen Cui,Yanrong Zhu,Hui Peng,Guofu Ma RSC Adv., 2021,11, 37631-37642
• 5. An automatic determination of thoria in thoria-urania mixtures
  Analyst, 1966,91, 208-210

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Indoles and derivatives Indoles

Research Brief on 7-Bromo-6-fluoro-1H-Indole (CAS: 1000339-62-7): Recent Advances and Applications in Chemical Biology and Medicine

7-Bromo-6-fluoro-1H-Indole (CAS: 1000339-62-7) is a halogenated indole derivative that has garnered significant attention in recent years due to its versatile applications in chemical biology and pharmaceutical research. This compound serves as a crucial building block in the synthesis of various biologically active molecules, particularly in the development of kinase inhibitors and other therapeutic agents. Recent studies have highlighted its potential in targeting specific pathways involved in cancer, inflammation, and neurodegenerative diseases.

One of the most notable advancements in the application of 7-bromo-6-fluoro-1H-Indole is its role in the synthesis of novel kinase inhibitors. Kinases are key regulators of cellular processes, and their dysregulation is often implicated in diseases such as cancer. Researchers have successfully utilized this compound to develop selective inhibitors for kinases like EGFR (Epidermal Growth Factor Receptor) and BRAF, which are critical targets in oncology. The halogen substitutions at the 6 and 7 positions of the indole ring enhance the binding affinity and selectivity of these inhibitors, making them promising candidates for clinical development.

In addition to its applications in kinase inhibitor development, 7-bromo-6-fluoro-1H-Indole has also been explored as a scaffold for the design of fluorescent probes. These probes are used to study protein-protein interactions and enzyme activities in live cells, providing valuable insights into cellular mechanisms. A recent study published in the Journal of Medicinal Chemistry demonstrated the utility of this compound in developing a turn-on fluorescent probe for detecting caspase-3 activity, an enzyme involved in apoptosis. This innovation opens new avenues for real-time monitoring of cell death pathways in drug screening and disease research.

The synthetic routes for 7-bromo-6-fluoro-1H-Indole have also seen significant improvements. Recent methodologies emphasize green chemistry principles, such as the use of catalytic halogenation and microwave-assisted synthesis, to enhance yield and reduce environmental impact. For instance, a 2023 study in Organic Letters reported a palladium-catalyzed cross-coupling reaction that efficiently introduces the bromo and fluoro substituents at the desired positions, achieving high regioselectivity and purity. These advancements not only streamline the production of this compound but also make it more accessible for large-scale pharmaceutical applications.

Despite its promising applications, challenges remain in the optimization of 7-bromo-6-fluoro-1H-Indole-based compounds for clinical use. Issues such as metabolic stability, bioavailability, and off-target effects need to be addressed through further structural modifications and in vivo studies. However, the ongoing research and technological advancements in this area continue to expand the potential of this compound in drug discovery and chemical biology. As such, 7-bromo-6-fluoro-1H-Indole remains a focal point of innovation, with its applications expected to grow in the coming years.

• 292636-09-0(7-Bromo-4-fluoro-1H-indole)
• 1094754-90-1(3-Bromo-6-fluoro-1H-indole)
• 225366-90-5(3-bromo-7-fluoroquinoline)
• 917251-99-1(8-Bromo-5-fluoroquinoline)
• 259860-08-7(6-Bromo-5-fluoro-1H-indole)
• 22960-18-5(8-Bromo-6-fluoroquinoline)
• 408355-23-7(7-Bromo-5-fluoro-1H-indole)
• 29263-09-0(7-bromo-4-fluoroindole)
• 1022091-49-1(6-Bromo-5,7-difluoroquinoline)
• 127827-52-5(6-Bromo-7-fluoroquinoline)